Article Text

PDF
Original article
A new face of Borjeson–Forssman–Lehmann syndrome? De novo mutations in PHF6 in seven females with a distinct phenotype
  1. Christiane Zweier1,
  2. Cornelia Kraus1,
  3. Louise Brueton1,
  4. Trevor Cole2,
  5. Franziska Degenhardt3,
  6. Hartmut Engels3,
  7. Gabriele Gillessen-Kaesbach4,
  8. Luitgard Graul-Neumann5,
  9. Denise Horn6,
  10. Juliane Hoyer1,
  11. Walter Just7,
  12. Anita Rauch8,
  13. André Reis1,
  14. Bernd Wollnik9,
  15. Michael Zeschnigk10,
  16. Hermann-Josef Lüdecke10,
  17. Dagmar Wieczorek10
  1. 1Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  2. 2Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK
  3. 3Institute of Human Genetics, Rheinische Friedrich Wilhelms-Universität, Bonn, Germany
  4. 4Institut für Humangenetik, Universität zu Lübeck, Lübeck, Germany
  5. 5Ambulantes Gesundheitszentrum, Charité Campus Virchow, Berlin, Germany
  6. 6Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany
  7. 7Institute of Human Genetics, University of Ulm, Ulm, Germany
  8. 8Institute of Medical Genetics, University of Zurich, Zurich-Schwerzenbach, Switzerland
  9. 9Institute of Human Genetics, Center for Molecular Medicine Cologne (CMMC), Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany
  10. 10Institut für Humangenetik, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany
  1. Correspondence to Dr Christiane Zweier, Institute of Human Genetics, Schwabachanlage 10, Erlangen 91054, Germany; christiane.zweier{at}uk-erlangen.de

Abstract

Background Borjeson–Forssman–Lehmann syndrome (BFLS) is an X-linked recessive intellectual disability (ID) disorder caused by mutations in the PHF6 gene and characterised by variable cognitive impairment, a distinct facial gestalt, obesity, and hypogonadism. Female carriers are usually not affected or only mildly affected, and so far only two females with de novo mutations or deletions in PHF6 have been reported.

Methods and results We performed PHF6 mutational analysis and screening for intragenic deletions and duplications by quantitative real-time PCR and multiplex ligation dependent probe amplification (MLPA) in female patients with variable ID and a distinct appearance of sparse hair, remarkable facial features, hypoplastic nails, and teeth anomalies. We detected two truncating mutations and two duplications of exons 4 and 5. Furthermore, two female patients with PHF6 deletions and a similar phenotype were identified by routine molecular karyotyping. Recently, two patients with a clinical diagnosis of Coffin-Siris syndrome in early infancy had been found to harbour mutations in PHF6, and their phenotype in advanced ages is now described. Further studies revealed skewed X-inactivation in blood lymphocytes, while it was normal in fibroblasts, thus indicating functional mosaicism.

Conclusions Our findings indicate that de novo defects in PHF6 in females result in a recognisable phenotype which might have been under-recognised so far and which comprises variable ID, a characteristic facial gestalt, hypoplastic nails, brachydactyly, clinodactyly mainly of fingers IV and V, dental anomalies, and linear skin hyperpigmentation. It shows overlap with BFLS but also additional distinct features, thus adding a new facet to this disorder.

  • Clinical genetics

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.